Couples Motivational Interviewing for Substance Abuse and HIV Risk
(CHP Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
Research shows that motivational interviewing (MI) is effective in reducing substance use and improving health-related behaviors. Studies have found that MI can help couples improve their relationship dynamics and communication, which are important for addressing substance use and HIV risk.
12345Motivational Interviewing (MI), including when used with couples, is generally considered safe as it is a non-judgmental, client-centered counseling style. The studies reviewed did not report any safety concerns, suggesting it is safe for use in humans.
12678Couples Motivational Interviewing is unique because it treats the couple as a unit rather than focusing on an individual, addressing both substance use and HIV risk by improving communication and resolving conflicts between partners. This approach leverages the dynamics of the relationship to facilitate change, which is particularly relevant for male couples where substance use and sexual health are interconnected.
128910Eligibility Criteria
This trial is for male couples where at least one partner has HIV and both are involved in drug use. They must be willing to participate together in interviews or counseling sessions aimed at reducing drug use and the risk of spreading HIV.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a three-session intervention focusing on couples communication skills, substance use, and sexual agreements, including couples HIV testing and counseling
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments on drug use, sexual behavior, and PrEP uptake
Participant Groups
Couples Motivational Interviewing is already approved in United States, Canada, European Union for the following indications:
- Substance use reduction
- HIV risk reduction
- Substance use reduction
- HIV risk reduction
- Substance use reduction
- HIV risk reduction